8C83

ICD-11 MMS 2026-01

Myopathy in certain specified endocrine disease

Description

Myopathy in certain specified endocrine disease refers to muscle disorders associated with adrenal dysfunction (as steroid myopathy), thyroid dysfunction (as in myxoedema coma or thyrotoxic myopathy), parathyroid dysfunction (as in multiple endocrine neoplasia), pituitary dysfunction, and islands of Langerhans dysfunction (as in diabetic myopathy from ischemic infarction of the femoral muscles). Steroid myopathy is the most common endocrine myopathy. These conditions are usually reversible with correction of the underlying endocrine disturbance.

Index terms

  • Myopathy in certain specified endocrine disease

Excludes

  • http://id.who.int/icd/entity/1425591047 – Myasthenia gravis or certain specified neuromuscular junction disorders
  • http://id.who.int/icd/entity/833816211 – Primary disorders of muscles

Exclusions from above levels

  • FB32.2 – Ischaemic infarction of muscle
  • LD26.41 – Arthrogryposis multiplex congenita
  • 05 – Endocrine, nutritional or metabolic diseases
Show allHide
  • 18 – Complications of pregnancy, childbirth and the puerperium
  • 19 – Certain conditions originating in the perinatal period
  • 22 – Injury, poisoning or certain other consequences of external causes

Sibling codes

  • 8C80 – Drug-induced myopathy
  • 8C81 – Autoimmune myopathy
  • 8C82 – Myopathy in certain specified infectious or parasitic disease
  • 8C84 – Secondary rhabdomyolysis
  • 8C8Y – Other specified secondary myopathies
  • 8C8Z – Secondary myopathies, unspecified

Foundation entity

Myopathy in certain specified endocrine disease – http://id.who.int/icd/entity/946840192

Allowed postcoordination axes

Part of: 08: Diseases of the nervous system